| RS2133312509 |
RAG2
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2133312597 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2133312718 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2133312827 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2133312873 |
RAG2
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2133313100 |
RAG2
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2133313409 |
RAG2
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, B cell-negative |
| RS2133313582 |
RAG2
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2133313716 |
RAG2
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2133313784 |
RAG2
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2133314424 |
RAG2
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2133314621 |
RAG2
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2133314949 |
TJP2
|
Health Risk |
Pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS2133315445 |
RAG2
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2133315462 |
RAG2
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2133316487 |
RAG2
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2133321113 |
LMBR1;ZRS
|
Health Risk |
Likely pathogenic |
Tibia, hypoplasia or aplasia of |
| RS2133322852 |
LAMC3
|
Health Risk |
Likely pathogenic |
Occipital pachygyria and polymicrogyria, Occipital pachygyria and polymicrogyria |
| RS2133325170 |
CACNB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 4, Cardiovascular phenotype |
| RS2133325416 |
NOTCH1
|
Health Risk |
Likely pathogenic |
Aortic valve disease 1, Aortic valve disease 1 |
| RS2133327116 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS2133328514 |
NOTCH1
|
Health Risk |
Likely pathogenic |
— |
| RS2133333494 |
NOTCH1
|
Health Risk |
Pathogenic |
NOTCH1-related disorder, NOTCH1-related disorder |
| RS2133335629 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS2133336162 |
PCDH15
|
Health Risk |
Likely pathogenic |
— |
| RS2133337500 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome, Adams-Oliver syndrome |
| RS2133337914 |
NOTCH1
|
Health Risk |
Likely pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS2133338569 |
NOTCH1
|
Health Risk |
Likely pathogenic |
— |
| RS2133339381 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS2133339552 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS2133342065 |
ODAD2
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 23, Primary ciliary dyskinesia 23 |
| RS2133343317 |
NOTCH1
|
Health Risk |
Likely pathogenic |
NOTCH1-related disorder, NOTCH1-related disorder |
| RS2133344193 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, NOTCH1-related disorder |
| RS2133344366 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS2133345379 |
NOTCH1
|
Health Risk |
Likely pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS2133346299 |
NOTCH1
|
Health Risk |
Pathogenic |
Keratoacanthoma, Keratoacanthoma |
| RS2133350738 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS2133352835 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic valve disease 1, Aortic valve disease 1 |
| RS2133358321 |
NOTCH1
|
Health Risk |
Likely pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS2133360646 |
NOTCH1
|
Health Risk |
Pathogenic |
KA-like vemurafenib-induced squamous lesions, KA-like vemurafenib-induced squamous lesions |
| RS2133361331 |
NOTCH1
|
Health Risk |
Likely pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS2133363840 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS2133364454 |
NOTCH1
|
Health Risk |
Likely pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS2133365083 |
DEAF1
|
Health Risk |
Pathogenic |
— |
| RS2133369937 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS2133369963 |
NOTCH1
|
Health Risk |
Likely pathogenic |
— |
| RS2133370541 |
NOTCH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Adams-Oliver syndrome 5, Familial thoracic aortic aneurysm and aortic dissection |
| RS2133372831 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS2133373175 |
RINT1
|
Health Risk |
Pathogenic |
— |
| RS2133373241 |
RINT1
|
Health Risk |
Pathogenic |
— |
| RS2133377407 |
DEAF1
|
Health Risk |
Likely pathogenic |
— |
| RS2133377568 |
NOTCH1
|
Health Risk |
Likely pathogenic |
— |
| RS2133377982 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS2133379125 |
KCNJ11
|
Health Risk |
Likely pathogenic |
— |
| RS2133379609 |
KCNJ11
|
Health Risk |
Likely pathogenic |
Neonatal diabetes mellitus, Neonatal diabetes mellitus |
| RS2133379669 |
IKZF5
|
Health Risk |
Pathogenic |
Thrombocytopenia 7, Thrombocytopenia 7 |
| RS2133379859 |
IKZF5
|
Health Risk |
Pathogenic |
Thrombocytopenia 7, Thrombocytopenia 7 |
| RS2133379889 |
IKZF5
|
Health Risk |
Pathogenic/Likely pathogenic |
Thrombocytopenia 7, Thrombocytopenia 7 |
| RS2133380076 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Permanent neonatal diabetes mellitus, Permanent neonatal diabetes mellitus |
| RS2133380463 |
KCNJ11
|
Health Risk |
Pathogenic |
— |
| RS2133382439 |
MPDZ
|
Health Risk |
Likely pathogenic |
— |
| RS2133384267 |
DEAF1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 24 |
| RS2133384423 |
FAS
|
Health Risk |
Likely pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2133384781 |
IKZF5
|
Health Risk |
Pathogenic/Likely pathogenic |
Thrombocytopenia 7, Thrombocytopenia 7 |
| RS2133385585 |
MPDZ
|
Health Risk |
Pathogenic |
— |
| RS2133390317 |
ABCC8
|
Health Risk |
Likely pathogenic |
Neonatal diabetes mellitus, Neonatal diabetes mellitus |
| RS2133392952 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2133393098 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2133393241 |
ABCC8
|
Health Risk |
Likely pathogenic |
Familial hyperinsulinism, Familial hyperinsulinism |
| RS2133394533 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2133394678 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2133394768 |
ABCC8
|
Health Risk |
Pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS2133394860 |
ABCC8
|
Health Risk |
Likely pathogenic |
— |
| RS2133394958 |
DEAF1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2133395050 |
DEAF1
|
Health Risk |
Pathogenic |
— |
| RS2133395056 |
BMPR1A
|
Health Risk |
Pathogenic |
Polyposis syndrome, hereditary mixed |
| RS2133395081 |
DEAF1
|
Health Risk |
Pathogenic |
Intellectual disability-epilepsy-extrapyramidal syndrome, Intellectual disability-epilepsy-extrapyramidal syndrome |
| RS2133395477 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2133398414 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2133398429 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2133400786 |
ABCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hyperinsulinism, Type 2 diabetes mellitus |
| RS2133400946 |
RINT1
|
Health Risk |
Likely pathogenic |
— |
| RS2133401009 |
ABCC8
|
Health Risk |
Likely pathogenic |
Neonatal diabetes mellitus, Neonatal diabetes mellitus |
| RS2133401493 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2133402124 |
DEAF1
|
Health Risk |
Pathogenic |
— |
| RS2133402346 |
DEAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 24 |
| RS2133402368 |
DEAF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 24 |
| RS2133402479 |
ABCC8
|
Health Risk |
Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS2133402508 |
DEAF1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 24 |
| RS2133402518 |
DEAF1
|
Health Risk |
Likely pathogenic |
— |
| RS2133402700 |
DEAF1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 24 |
| RS2133402741 |
DEAF1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 24 |
| RS2133406667 |
DEAF1
|
Health Risk |
Pathogenic |
— |
| RS2133407387 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2133408466 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2133408572 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2133408684 |
NOTCH1
|
Health Risk |
Likely pathogenic |
— |
| RS2133408741 |
BMPR1A
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2133409163 |
BMPR1A
|
Health Risk |
Likely pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2133411275 |
LIPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Lysosomal acid lipase deficiency, Wolman disease |